Concord Medical Services Holdings Limited (NYSE:CCM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Concord Medical Services Holdings Limited operates a large network of radiotherapy and diagnostic imaging centers in China. Most of the centers in their network are established through long-term lease and management services arrangements entered into with their hospital partners. Under these arrangements, Concord Medical receives a contracted percentage of each center’s revenue net of specified operating expenses. Each center is located on the premises of their hospital partners and is typically equipped with a primary unit of advanced radiotherapy or diagnostic imaging equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, PET-CT scanner or MRI scanner. “

Concord Medical Services Holdings Limited (NYSE:CCM) traded up 0.50% during trading on Wednesday, hitting $4.03. 4,680 shares of the stock were exchanged. The stock’s 50-day moving average price is $3.85 and its 200-day moving average price is $4.30. Concord Medical Services Holdings Limited has a 12-month low of $3.22 and a 12-month high of $4.96. The firm’s market cap is $176.01 million.

COPYRIGHT VIOLATION NOTICE: This report was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/concord-medical-services-holdings-limited-nyseccm-downgraded-to-hold-at-zacks-investment-research/1466135.html.

A hedge fund recently raised its stake in Concord Medical Services Holdings Limited stock. Renaissance Technologies LLC boosted its stake in Concord Medical Services Holdings Limited (NYSE:CCM) by 4.3% during the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 134,500 shares of the company’s stock after buying an additional 5,600 shares during the period. Renaissance Technologies LLC owned 0.92% of Concord Medical Services Holdings Limited worth $618,000 at the end of the most recent reporting period. Institutional investors own 12.46% of the company’s stock.

About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.

Get a free copy of the Zacks research report on Concord Medical Services Holdings Limited (CCM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Concord Medical Services Holdings Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services Holdings Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.